11:20 AM EST - Delivra Corp : Has signed a joint venture agreement using Delivra's revolutionary, proprietary topical therapeutic platform. The Delivra™ topical base cream can accommodate hundreds of molecules that can be used for the human and animal health sectors. Delivra Corp
shares V.DVA are trading up $0.005 at $0.46.
